Payer+Provider Syndicate helps healthcare organizations demonstrate value. We support evidence development, economic analysis, and reimbursement strategy by translating clinical outcomes, costs, and operational realities into clear, defensible arguments for adoption, coverage, and investment.
These engagements are most relevant when an organization must justify a product, service, model of care, or operational change to payers, providers, reviewers, or internal decision-makers. Our work focuses on building evidence and analyses that can withstand scrutiny and support real-world decisions.
When Organizations Call Us
Uncertain Reimbursement
A product or service lacks a clear coverage pathway and requires a structured case for reimbursement, medical necessity, or broader support.
Need to Demonstrate ROI
An organization must quantify costs and benefits across stakeholders to support investment, contracting, or adoption decisions.
Limited Published Evidence
Existing literature is insufficient to support adoption, requiring structured evidence development, synthesis, or research planning.
Need for Reviewer-Facing Materials
Leadership needs concise, credible materials that physicians, payers, or executives can review quickly without deep subject-matter expertise.
What We Focus On
Who Pays
We identify which stakeholders bear the costs and how those costs arrive over time.
Who Benefits
We determine which stakeholders receive the clinical, financial, operational, or strategic benefits.
When Effects Arrive
We examine timing explicitly, because immediate costs and delayed benefits are evaluated differently in real decisions.
How Strong the Evidence Is
We assess the strength of available evidence, the assumptions being made, and the uncertainty decision-makers must accept.
What We Do
We offer organizations a turnkey approach to research, from ideation to dissemination. We begin by defining the decision context. That means clarifying what is being justified, who must be persuaded, what evidence already exists, which stakeholders matter most, and what type of argument is likely to influence the decision at hand. From there, we gather and analyze the data needed to support that argument, which may include published literature, outcomes data, utilization patterns, costs, workflows, and operational considerations.
Depending on the engagement, this work may involve literature review, evidence synthesis, outcomes analysis, economic modeling, evidence packet development, and synthesis of qualitative and quantitative findings. We also help clients think prospectively about where evidence is still missing and what additional studies, abstracts, posters, white papers, or manuscripts may be needed to strengthen their position over time.
We then translate findings into formats that can be used in real decision-making contexts, including internal investment discussions, payer conversations, and client conversations. If desired, findings can be submitted to professional society conferences for presentation or can be published in peer-reviewed journals. These outputs produce lasting artifacts that organizations can use as proof of prior performance.
Typical Deliverables
ROI and Economic Models
Structured analyses of costs and benefits across stakeholders, including timing, uncertainty, and operational implications.
Evidence Packets
Curated sets of peer-reviewed studies and supporting materials with concise summaries tailored to non-specialist reviewers.
Outcomes Research
Design and execution of analyses that demonstrate clinical, functional, or utilization impact.
Abstracts, Posters, and Manuscripts
Research outputs designed for conference presentation, public dissemination, or peer-reviewed publication.
White Papers
Clear materials that translate complex findings into action-oriented insights for leadership and external stakeholders.
Evidence-Gap and Research Roadmaps
Assessment of where additional research is needed and how future evidence development should be prioritized.
How We Typically Work
Define the Analytical Question
Clarify the decision context, stakeholders, audiences, and key uncertainties that must be addressed.
Gather Data and Evidence
Collect relevant clinical, financial, operational, and literature-based inputs.
Analyze Costs and Outcomes
Evaluate benefits, risks, tradeoffs, and timing, including how they vary across stakeholders.
Identify Evidence Gaps
Determine where additional research, synthesis, or reviewer-facing materials are needed.
Translate Findings
Prepare concise, decision-oriented materials for executives, physicians, payers, or conference audiences.
Support Dissemination
When appropriate, help turn findings into abstracts, posters, white papers, or peer-reviewed manuscripts.
Featured Example
ROI Analysis
We help organizations evaluate the return on investment of healthcare products, services, and innovations by analyzing costs and benefits from the perspective of each relevant stakeholder.
Representative Situations
Supporting Coverage Discussions
An organization needs to present a structured case regarding why a service should be covered, reimbursed, or otherwise supported.
Justifying Investment
Leadership must decide whether to invest in a product, service, or program based on expected returns, risks, and strategic fit.
Building an Evidence Base
A company or provider must develop or synthesize evidence to support adoption, credibility, and external communication.
Preparing Reviewer-Facing Materials
Decision-makers need concise materials that summarize findings clearly enough for fast, credible review.
Select Related Publications
A Patient-Centered Framework for Measuring the Economic Value of Clinical Benefits
Illustrates our focus on stakeholder-specific value, timing, and the practical interpretation of benefits rather than simple top-line claims.
Reimbursement of Apps for Mental Health
Highlights the practical reimbursement challenge directly: even when a digital solution appears clinically useful, payment pathways are often fragmented, inconsistent, or underdeveloped.
Related Pages
See also
- ROI Analysis
A more focused example of stakeholder-specific economic analysis. - Utilization Management, Coverage Guidance, and Decision Support
Relevant when evidence must support appropriateness criteria, coverage logic, or administrative interventions. - Commercialization and Market Development
Relevant when evidence and economics must be translated into market-facing adoption strategy.
Why Payer+Provider Syndicate
We approach evidence and economics with a practical perspective grounded in how decisions are actually made in healthcare. By integrating clinical outcomes, financial considerations, stakeholder incentives, and operational realities, we help organizations develop analyses that are technically sound, strategically useful, and credible with the audiences that matter.